1. Home

Continuing Medical Education Information 

TO CLAIM CREDIT AND DOWNLOAD A CERTIFICATE (INCLUDING CERTIFICATES OF PARTICIPATION): Go to the web portal. 

Jointly provided by The France Foundation and the Kidney Cancer Association. 


TARGET AUDIENCE
This educational activity is intended for medical oncologists and urologists who treat patients with kidney cancer. All other healthcare professionals involved in the management of kidney cancer are invited to participate. 

STATEMENT OF NEED
Education and interaction surrounding the space of renal cell carcinoma are paramount to improving patient care. This program is targeted to physicians, advocates, and researchers to help promote learning and collaboration for advancement in the renal cancer space. 

EDUCATIONAL ACTIVITY LEARNING OBJECTIVES
Upon completion of this course, the participants should be able to: 

• Characterize the various therapies currently available for locally advanced and metastatic renal cell carcinoma. 
• Identify the novel approaches to non-clear cell RCC patient management. 
• Understand the role of the tumor microenvironment in kidney cancer.
• Discuss how to design biomarker driven clinical trials in kidney cancer. 

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Kidney Cancer Association. The France Foundation is accredited by ACCME to provide continuing medical education for physicians. 

CREDIT DESIGNATION

Physicians: The France Foundation designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 



The 2022 IKCS: Europe - International Kidney Cancer Symposium, Antwerp, Belgium, 22/04/2022- 24/04/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13.75 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

METHOD OF PARTICIPATION AND HOW TO RECEIVE CREDIT

1. Review the activity objectives and CME/CE information. 
2. Participate in the CME/CE activity. 
3. TO CLAIM CREDIT: Go to the web portal.
4. Complete the evaluation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her/their views on future educational needs. 
5. Submit your information to generate your certificate. 
6. Download/Print your certificate: If you are requesting educational credits or a certificate of participation, your certificate will be available for download. 

DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) and The Kidney Cancer Association (KCA) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and KCA resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and KCA see to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and KCA are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commerical interest. 

View disclosures for all IKCS: Europe Planners and Faculty. 

DISCLOSURE OF UNLABLED USE
TFF and KCA require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of the US Food and Drug Administration approved labeling. This information is intended soley for continuing medical education and is not intended to promote off-label use of these medications. TFF and KCA do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information. 

DISCLAIMER 
The France Foundation and the Kidney Cancer Association present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have hte professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgement and accepted standards of care. The France Foundation and the Kidney Cancer Association assume no liability for the information herein. 

Note: Missing disclosures were not submitted in time for printing. Their disclosures will be available during their session talks.